Cargando…
The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
OBJECTIVE: Neoadjuvant chemotherapy (NAC) is currently used in both early stage and locally advanced breast cancers. The survival benefits of standard vs. non-standard NAC cycles are still unclear. This study aimed to investigate the relationship between NAC cycles and survival based on real world d...
Autores principales: | Yao, Litong, Pang, Zhiyuan, Wang, Mozhi, Wang, Mengshen, Sun, Xiangyu, Cui, Mingke, Zheng, Yanfu, Li, Xinyan, Dong, Haoran, Zhang, Qiang, Xu, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196050/ https://www.ncbi.nlm.nih.gov/pubmed/34633775 http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0800 |
Ejemplares similares
-
An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
por: Wang, Mozhi, et al.
Publicado: (2021) -
Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
por: Li, Xinyan, et al.
Publicado: (2019) -
Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?—a meta-analysis of randomized controlled trials
por: Dong, Haoran, et al.
Publicado: (2020) -
Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
por: Li, Xinyan, et al.
Publicado: (2020) -
Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)